XLRN

InterMune Slumps: ITMN Falls 14.9% in Session

moreView todays social media effects on XLRNView the latest stocks trending across Twitter. Click to view dashboardSee who Acceleron is hiring next, click here to view […]

Acceleron Pharma Reports Fourth Quarter and Year Ended 2013 Financial Results

[Business Wire] – Acceleron Pharma Inc. , a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer moreView todays social media effects on XLRNView the latest stocks trending across Twitter. Click to view dashboardSee who Acceleron is hiring next, click here to view […]

Acceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014

[at noodls] – CAMBRIDGE, Mass.–(BUSINESS WIRE)– Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics … moreView todays social media effects on XLRNView the latest stocks trending across Twitter. Click to view dashboardSee who Acceleron is hiring next, click here to view […]

Acceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014

[Business Wire] – Acceleron Pharma Inc. , a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer moreView todays social media effects on XLRNView the latest stocks trending across Twitter. Click to view dashboardSee who Acceleron is hiring next, click here to view […]